The Worldwide Industry for Wearable Cardioverter Defibrillators is Expected to Reach Around $1.1 Billion by 2028
January 15, 2021 08:03 ET
|
Research and Markets
Dublin, Jan. 15, 2021 (GLOBE NEWSWIRE) -- The "Global Wearable Cardioverter Defibrillator Market Outlook 2028" report has been added to ResearchAndMarkets.com's offering. The value of global...
Defibrillator Market Forecast Report 2020: Focus on US, Germany, Spain, Italy, France, United Kingdom and Japan
January 08, 2021 06:38 ET
|
Research and Markets
Dublin, Jan. 08, 2021 (GLOBE NEWSWIRE) -- The "Defibrillator - Market Insights, Competitive Landscape and Market Forecast - 2025" report has been added to ResearchAndMarkets.com's offering. This...
Global $10.08 Billion Defibrillators (Implantable Cardioverter & External) Market Opportunity Analysis and Industry Forecast to 2026
September 14, 2020 06:48 ET
|
Research and Markets
Dublin, Sept. 14, 2020 (GLOBE NEWSWIRE) -- The "Defibrillators Market by Type, and External Defibrillators), by End User, by Geography Global Opportunity Analysis and Industry Forecast up to 2026"...
CBRS Alliance Celebrates Availability of OnGo™ Service in 3.5 GHz CBRS Band at Pivotal Launch Event
September 18, 2019 11:31 ET
|
CBRS Alliance
WASHINGTON, Sept. 18, 2019 (GLOBE NEWSWIRE) -- Today, the CBRS Alliance, an industry organization focused on driving the development, commercialization, and adoption of OnGo™ shared spectrum...
FCC Authorizes Historic OnGo™ Deployments in 3.5 GHz CBRS Band, Opens Billions in Economic Opportunity for U.S.
September 16, 2019 11:56 ET
|
CBRS Alliance
SUNNYVALE, Calif., Sept. 16, 2019 (GLOBE NEWSWIRE) -- The CBRS Alliance, an industry organization focused on driving the development, commercialization, and adoption of OnGo™ shared spectrum...
US FDA GRANTS PV-10 ORPHAN DRUG DESIGNATION FOR NEUROBLASTOMA
November 05, 2018 08:00 ET
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, Nov. 05, 2018 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that the Company was granted orphan drug designation (ODD) by the U.S. Food and Drug Administration (FDA)...
Heart Implant Patients' Fears About Shock Leads to Sexual Dysfunction
November 14, 2011 10:10 ET
|
American Heart Association
Study Highlights:
Adults with congenital heart disease who have implanted defibrillators often have shock-related anxiety about the device delivering a shock during sex.
The anxiety can...